乌干达实施“治疗即预防”后，CD4 计数检测次数减少。
Reduction in Baseline CD4 Count Testing Following Human Immunodeficiency Virus "Treat All" Adoption in Uganda.
机构信息
Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
出版信息
Clin Infect Dis. 2020 Dec 3;71(9):2497-2499. doi: 10.1093/cid/ciaa261.
Abstract
Baseline CD4 testing rates declined from 73% to 21% between 2013 and 2018 with adoption of "Treat All" in Uganda. Advanced human immunodeficiency virus (HIV) disease (CD4 count < 200 cells/µL) remained common (24% of those tested in 2018, 83% of whom had World Health Organization stage I/II disease). Despite frequent presentation with advanced HIV disease, CD4 testing has declined dramatically.
摘要
在乌干达采用“治疗所有”策略后，2013 年至 2018 年期间，基础 CD4 检测率从 73%下降至 21%。晚期人类免疫缺陷病毒（HIV）疾病（CD4 计数 < 200 个/µL）仍然很常见（2018 年接受检测的人群中有 24%，其中 83%患有世界卫生组织 I/II 期疾病）。尽管经常出现晚期 HIV 疾病，但 CD4 检测却大幅下降。
相似文献
1
Reduction in Baseline CD4 Count Testing Following Human Immunodeficiency Virus "Treat All" Adoption in Uganda.乌干达实施“治疗即预防”后，CD4 计数检测次数减少。
Clin Infect Dis. 2020 Dec 3;71(9):2497-2499. doi: 10.1093/cid/ciaa261.
2
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.接受强效抗逆转录病毒治疗4年的晚期HIV-1感染个体的CD4 T淋巴细胞恢复情况：瑞士HIV队列研究
Arch Intern Med. 2003 Oct 13;163(18):2187-95. doi: 10.1001/archinte.163.18.2187.
3
Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda.基于社区的 HIV 检测后抗逆转录病毒治疗和男性包皮环切术的采用以及与护理衔接的策略与标准诊所转诊的比较：南非和乌干达的多中心、开放性标签、随机对照试验
Lancet HIV. 2016 May;3(5):e212-20. doi: 10.1016/S2352-3018(16)00020-5. Epub 2016 Mar 10.
4
Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.启动三联药物治疗后，按基线CD4细胞计数和病毒载量划分的疾病进展率。
JAMA. 2001 Nov 28;286(20):2568-77. doi: 10.1001/jama.286.20.2568.
5
CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.在接受高效抗逆转录病毒治疗并实现持续病毒学抑制的患者中，治疗开始6年后的CD4 +细胞计数。
Clin Infect Dis. 2007 Feb 1;44(3):441-6. doi: 10.1086/510746. Epub 2006 Dec 20.
6
Evaluation of the effectiveness of highly active antiretroviral therapy in persons with human immunodeficiency virus using biomarker-based equivalence of disease progression.使用基于生物标志物的疾病进展等效性评估高效抗逆转录病毒疗法对人类免疫缺陷病毒感染者的有效性。
Am J Epidemiol. 2002 Apr 15;155(8):760-70. doi: 10.1093/aje/155.8.760.
7
Long-term experience providing antiretroviral drugs in a fee-for-service HIV clinic in Uganda: evidence of extended virologic and CD4+ cell count responses.
J Acquir Immune Defic Syndr. 2005 Apr 15;38(5):578-83. doi: 10.1097/01.qai.0000134742.26338.2f.
8
CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa.撒哈拉以南非洲地区开始接受抗逆转录病毒治疗的免疫严重缺陷的艾滋病毒感染患者的CD4细胞计数恢复情况。
BMC Infect Dis. 2006 Mar 21;6:59. doi: 10.1186/1471-2334-6-59.
9
Late presentation for human immunodeficiency virus HIV diagnosis results of a Belgian single centre.比利时单中心人类免疫缺陷病毒（HIV）诊断延迟呈现的结果
Acta Clin Belg. 2014 Jan-Feb;69(1):33-9. doi: 10.1179/0001551213Z.00000000014.
10
When to begin highly active antiretroviral therapy? Evidence supporting initiation of therapy at CD4+ lymphocyte counts <350 cells/microL.何时开始高效抗逆转录病毒治疗？支持在CD4 +淋巴细胞计数<350个细胞/微升时开始治疗的证据。
Clin Infect Dis. 2003 Oct 1;37(7):951-8. doi: 10.1086/377606. Epub 2003 Sep 12.
引用本文的文献
1
Incidence and risk factors for tuberculosis at a rural HIV clinic in Uganda, 2012-2019; A retrospective cohort study.2012 - 2019年乌干达一家农村艾滋病诊所的结核病发病率及危险因素：一项回顾性队列研究
BMC Public Health. 2025 May 22;25(1):1882. doi: 10.1186/s12889-025-23090-8.
2
A Prospective Evaluation of the Diagnostic Accuracy of the Point-of-Care VISITECT CD4 Advanced Disease Test in 7 Countries.7个国家即时检验VISITECT CD4晚期疾病检测诊断准确性的前瞻性评估
J Infect Dis. 2025 Feb 4;231(1):e82-e90. doi: 10.1093/infdis/jiae374.
3
The effect of the Universal Test and Treat policy uptake on CD4 count testing and incidence of opportunistic infections among people living with HIV infection in Cameroon: a retrospective analysis of routine data.普遍检测与治疗政策的实施对喀麦隆艾滋病毒感染者的CD4细胞计数检测及机会性感染发生率的影响：常规数据的回顾性分析
Dialogues Health. 2023 Feb 26;2:100120. doi: 10.1016/j.dialog.2023.100120. eCollection 2023 Dec.
4
Sensitivity and specificity of CRP and symptom screening as tuberculosis screening tools among HIV-positive and negative outpatients at a primary healthcare facility in Lusaka, Zambia: a prospective cross-sectional study.赞比亚卢萨卡一家初级保健机构中，针对 HIV 阳性和阴性门诊患者，使用 CRP 和症状筛查作为结核病筛查工具的敏感性和特异性：一项前瞻性横断面研究。
BMJ Open. 2023 Apr 18;13(4):e061907. doi: 10.1136/bmjopen-2022-061907.
5
Advanced HIV disease and associated attrition after re-engagement in HIV care in Myanmar from 2003 to 2019: a retrospective cohort study.2003 年至 2019 年缅甸重新参与艾滋病毒护理后，艾滋病毒疾病的晚期和相关损耗：一项回顾性队列研究。
Int Health. 2023 Jul 4;15(4):453-461. doi: 10.1093/inthealth/ihac069.
6
Cost-effectiveness of single-dose AmBisome pre-emptive treatment for the prevention of cryptococcal meningitis in African low and middle-income countries.在非洲低收入和中等收入国家，单剂量两性霉素B脂质体抢先治疗预防隐球菌性脑膜炎的成本效益分析
Med Mycol. 2022 Feb 1;60(2). doi: 10.1093/mmy/myab078.
7
Effects of implementing universal and rapid HIV treatment on initiation of antiretroviral therapy and retention in care in Zambia: a natural experiment using regression discontinuity.在赞比亚实施普遍快速的 HIV 治疗对启动抗逆转录病毒治疗和保留在护理中的影响：使用回归不连续的自然实验
Lancet HIV. 2021 Dec;8(12):e755-e765. doi: 10.1016/S2352-3018(21)00186-7. Epub 2021 Oct 14.
8
Utility of CD4 count measurement in the era of universal antiretroviral therapy: an analysis of routine laboratory data in Botswana.在普遍开展抗逆转录病毒治疗的时代，CD4 计数检测的实用性：博茨瓦纳常规实验室数据的分析。
HIV Med. 2021 Jan;22(1):1-10. doi: 10.1111/hiv.12951. Epub 2020 Sep 2.
9
The Enduring Burden of Advanced Human Immunodeficiency Virus Disease.晚期人类免疫缺陷病毒病的持续负担
Clin Infect Dis. 2020 Dec 3;71(9):2500-2501. doi: 10.1093/cid/ciaa265.
本文引用的文献
1
Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial.在非洲住院的 HIV 阳性患者中基于尿液的快速结核病筛查（STAMP）：一项实用、多中心、平行组、双盲、随机对照试验。
Lancet. 2018 Jul 28;392(10144):292-301. doi: 10.1016/S0140-6736(18)31267-4. Epub 2018 Jul 20.
2
Persistent High Burden of Advanced HIV Disease Among Patients Seeking Care in South Africa's National HIV Program: Data From a Nationwide Laboratory Cohort.南非国家艾滋病毒规划中寻求治疗的患者中持续存在大量晚期艾滋病疾病负担：来自全国性实验室队列的数据。
Clin Infect Dis. 2018 Mar 4;66(suppl_2):S111-S117. doi: 10.1093/cid/ciy045.
3
Advanced Human Immunodeficiency Virus Disease at Diagnosis in Mozambique and Swaziland.莫桑比克和斯威士兰确诊时的晚期人类免疫缺陷病毒病
Open Forum Infect Dis. 2017 Jul 23;4(3):ofx156. doi: 10.1093/ofid/ofx156. eCollection 2017 Summer.
4
Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa.非洲晚期HIV感染的强化预防加抗逆转录病毒治疗
N Engl J Med. 2017 Jul 20;377(3):233-245. doi: 10.1056/NEJMoa1615822.
5
Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial.基于即时检测的尿液脂阿拉伯甘露聚糖检测对指导 HIV 阳性住院患者启动结核病治疗的效果：一项在多国进行的实用、平行分组、开放标签、随机对照试验。
Lancet. 2016 Mar 19;387(10024):1187-97. doi: 10.1016/S0140-6736(15)01092-2. Epub 2016 Mar 10.
6
Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial.在坦桑尼亚和赞比亚，对开始接受抗逆转录病毒治疗的晚期 HIV 感染患者进行隐球菌性脑膜炎筛查和基于社区的早期依从性支持：一项开放标签、随机对照试验。
Lancet. 2015 May 30;385(9983):2173-82. doi: 10.1016/S0140-6736(15)60164-7. Epub 2015 Mar 10.
7
Diagnostic accuracy of the WHO clinical staging system for defining eligibility for ART in sub-Saharan Africa: a systematic review and meta-analysis.世界卫生组织临床分期系统在撒哈拉以南非洲地区确定抗逆转录病毒治疗资格方面的诊断准确性：一项系统评价和荟萃分析
J Int AIDS Soc. 2014 Jun 12;17(1):18932. doi: 10.7448/IAS.17.1.18932. eCollection 2014.
8
Reduction in early mortality on antiretroviral therapy for adults in rural South Africa since change in CD4+ cell count eligibility criteria.南非农村地区改变 CD4+ 细胞计数资格标准后，成人抗逆转录病毒治疗的早期死亡率降低。
J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):e17-24. doi: 10.1097/QAI.0b013e31829ceb14.
9
Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort.在开始联合抗逆转录病毒治疗的情况下，在非洲严重免疫抑制的 HIV 感染成人中每日联合使用甲氧苄啶-磺胺甲噁唑预防：对 DART 队列的观察性分析。
Lancet. 2010 Apr 10;375(9722):1278-86. doi: 10.1016/S0140-6736(10)60057-8. Epub 2010 Mar 27.
Zotero 插件